SPDR Series Trust SPDR S&P Biotech ETF (XBI): Price and Financial Metrics ETF
XBI Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $101.54 | 52-week high | $103.52 |
Prev. close | $100.98 | 52-week low | $63.80 |
Day low | $100.96 | Volume | 8,299,100 |
Day high | $103.08 | Avg. volume | 10,386,546 |
50-day MA | $93.62 | Dividend yield | 0.13% |
200-day MA | $87.02 |
XBI Stock Price Chart Interactive Chart >
SPDR Series Trust SPDR S&P Biotech ETF (XBI) ETF Bio
The investment objective of the SPDR S&P Biotech ETF is to provide investment results that correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.
XBI ETF Info
Issuer | State Street Global Advisors |
Expense Ratio | 0.35% |
Underlying Index | S&P Biotechnology Select Industry Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 7.79B |
Net Asset Value (NAV) | $101.03 |
Options? | Yes |
Total Holdings | 144 |
XBI Top Holdings
Symbol | Company | % of Total |
UTHR | UNITED THERAPEUTICS CORP | 2.9% |
EXAS | EXACT SCIENCES CORP | 2.88% |
SRPT | SAREPTA THERAPEUTICS INC | 2.86% |
GILD | GILEAD SCIENCES INC | 2.85% |
AMGN | AMGEN INC | 2.83% |
ABBV | ABBVIE INC | 2.63% |
ALNY | ALNYLAM PHARMACEUTICALS INC | 2.61% |
REGN | REGENERON PHARMACEUTICALS | 2.58% |
INCY | INCYTE CORP | 2.57% |
VRTX | VERTEX PHARMACEUTICALS INC | 2.57% |
XBI Price Returns
1-mo | 10.14% |
3-mo | 21.77% |
6-mo | 15.22% |
1-year | 24.35% |
3-year | -17.31% |
5-year | 19.01% |
YTD | 13.86% |
2023 | 7.60% |
2022 | -25.87% |
2021 | -20.45% |
2020 | 48.33% |
2019 | 32.56% |
XBI Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |